The Effect of Social Media-Based Education on the Knowledge and Attitudes of Women of Childbearing Age in the Preconception Period and on Healthy Lifestyle Behaviors

July 21, 2025 updated by: YASEMİN AYDIN KARTAL, Saglik Bilimleri Universitesi
In order to determine the effect of education provided through social media on the knowledge and attitudes of women of childbearing age during the preconceptional period and its relationship with healthy lifestyle behaviors, a randomized controlled pre-test and post-test design and control group was planned. The research universe will consist of women of childbearing age who applied to Ümraniye Education and Research Hospital, agreed to participate in the study and met the inclusion criteria (N: 80). In this randomized controlled pre-test and post-test design and control group study, in order to determine the sample size; the data were normally distributed, the standard deviation of the main mass was estimated as 1 and the effect size (difference) was estimated as 0.8. For the analysis to be conducted, it was calculated that the highest power value of the study would be 0.942182 if two independent n₁=40, n₂=40 samples were taken at a significance level of 5%. The G-power analysis result is given below. In addition, after the data collection, the adequacy of the sample size in the study will be evaluated with a post hoc power analysis. Women who volunteer to participate in the study will be assigned to the intervention and control groups using a computer-aided simple random sampling method. Computer-aided randomization will be used in the study, and the number of cases will be entered through the program with the URL address https://www.randomizer.org and random assignment will be made to the intervention and control groups. Preconceptional period education will be provided to the women in the intervention group via social media. No application will be made to the control group.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
80

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
      • Istanbul, Turkey
        • University of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being willing to participate in the study.
  • Being a woman of childbearing age
  • Planning to get pregnant within 1 year
  • Using Instagram and WhatsApp

Exclusion Criteria:

- Being pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention group (n:40)
Participants in the intervention group will be required to follow the Instagram account created specifically for the training. The Instagram account will be made private to prevent women in the control group from accessing Instagram posts. The training provided via Instagram will last 2 weeks, including the process of sharing all posts and videos. After the completion of the training, the "Healthy Lifestyle Behaviors Scale" and the "Preconceptional Knowledge and Attitude Scale" will be applied as a post-test.
Other: Social media based education
Participants in the intervention group will be required to follow the Instagram account created specifically for the training. The Instagram account will be made private to prevent women in the control group from accessing Instagram posts. The training provided via Instagram will last 2 weeks, including the process of sharing all posts and videos. After the completion of the training, the "Healthy Lifestyle Behaviors Scale" and the "Preconceptional Knowledge and Attitude Scale" will be applied as a post-test.
No Intervention: Control group (n:40
No application will be made. After all stages of the research are completed, training will be applied to the control group participants. After the research is completed, all participants will be given a brochure containing the information in the training content.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Introductory Information Form
Time Frame: 10 minutes
This form, created by researchers based on literature, includes questions about the participants' age, obstetric history, healthy lifestyle behaviors, etc.
10 minutes
Healthy Lifestyle Behaviors Scale (HLBS-II)
Time Frame: 10 minutes
The scale, whose validity and reliability study was conducted in our country by Bahar et al. in 2008, was developed by Walker et al. in 1996 to measure the health-enhancing behaviors of the individual in relation to a healthy lifestyle. The scale has six sub-dimensions: health responsibility (3,9,15,21,27,33,39,45,51), physical activity (4,10,16,22,28,34,40,46), nutrition (2,8,14,20,26,32,38,44,50), spiritual development (6,12,18,24,30,36,42,48,52), interpersonal relations (1,7,13,19,25,31,37,43,49) and stress management (5,11,17,23,29,35,41,47) and consists of a total of 52 items. The interpersonal relations scale sub-dimension evaluates the relationships between the individual and the environment. Communication is necessary in a healthy relationship.
10 minutes
Preconceptional Knowledge and Attitude Scale
Time Frame: 10 minutes
It was developed by Gökdemir and Eryılmaz in 2022. The original language of the scale is Turkish and it is a 5-point Likert type. The scale can be applied to married and single women between the ages of 18-45 who are of childbearing age. The Preconceptional Knowledge and Attitude Scale consists of a total of 43 items, 42 positive (straight) and 1 negative (reverse) item, and 7 sub-dimensions (factors). The distribution of the items in the scale to the factors is as follows. Factor 1 (Attitudes Towards Preconceptional Health Protection and Development): There are a total of 10 items in this dimension, consisting of items 10, 15, 17, 18, 19, 21, 23, 25, 26, and 31. Factor 2 (Attitudes Towards Fertility Planning): This dimension consists of items 28, 30, 32, 34, 38, 39, and 40, and has a total of 7 items. Factor 3 (Attitudes Towards Living Conditions Before Having Children): This dimension consists of items 27, 29, 41, 35, and 42, and has a total of 5 items.
10 minutes

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Introductory Information Form
Time Frame: 10 minutes
This form, created by researchers based on literature, includes questions about the participants' age, obstetric history, healthy lifestyle behaviors, etc.
10 minutes
Healthy Lifestyle Behaviors Scale (HLBS-II)
Time Frame: 10 minutes
The scale, whose validity and reliability study was conducted in our country by Bahar et al. in 2008, was developed by Walker et al. in 1996 to measure the health-enhancing behaviors of the individual in relation to a healthy lifestyle. The scale has six sub-dimensions: health responsibility (3,9,15,21,27,33,39,45,51), physical activity (4,10,16,22,28,34,40,46), nutrition (2,8,14,20,26,32,38,44,50), spiritual development (6,12,18,24,30,36,42,48,52), interpersonal relations (1,7,13,19,25,31,37,43,49) and stress management (5,11,17,23,29,35,41,47) and consists of a total of 52 items. The interpersonal relations scale sub-dimension evaluates the relationships between the individual and the environment. Communication is necessary in a healthy relationship.
10 minutes
Preconceptional Knowledge and Attitude Scale
Time Frame: 10 minutes
It was developed by Gökdemir and Eryılmaz in 2022. The original language of the scale is Turkish and it is a 5-point Likert type. The scale can be applied to married and single women between the ages of 18-45 who are of childbearing age. The Preconceptional Knowledge and Attitude Scale consists of a total of 43 items, 42 positive (straight) and 1 negative (reverse) item, and 7 sub-dimensions (factors). The distribution of the items in the scale to the factors is as follows. Factor 1 (Attitudes Towards Preconceptional Health Protection and Development): There are a total of 10 items in this dimension, consisting of items 10, 15, 17, 18, 19, 21, 23, 25, 26, and 31. Factor 2 (Attitudes Towards Fertility Planning): This dimension consists of items 28, 30, 32, 34, 38, 39, and 40, and has a total of 7 items. Factor 3 (Attitudes Towards Living Conditions Before Having Children): This dimension consists of items 27, 29, 41, 35, and 42, and has a total of 5 items.
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 5, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 5, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 5, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 7, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 21, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 24, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 24, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 21, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • SBU-AYDINKARTAL-012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings